These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7517054)

  • 21. Laser nephelometric assay of complements C3 & C4 in unselected Nigerian population.
    Kazeem AA
    West Afr J Med; 1989; 8(1):38-41. PubMed ID: 2486770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity chromatography of thiol ester-containing proteins.
    Houen G; Svendsen I
    J Chromatogr A; 1998 Mar; 799(1-2):139-48. PubMed ID: 9550106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin.
    Tack BF
    Springer Semin Immunopathol; 1983; 6(4):259-82. PubMed ID: 6198737
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation and initial characterisation of complement components C3 and C4 of the nurse shark and the channel catfish.
    Dodds AW; Smith SL; Levine RP; Willis AC
    Dev Comp Immunol; 1998; 22(2):207-16. PubMed ID: 9639090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
    Ogata RT; Low PJ
    J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chemical approach to immunoprotein engineering: chemoselective functionalization of thioester proteins in their native state.
    Cole MA; Tully SE; Dodds AW; Arnold JN; Boldt GE; Sim RB; Offer J; Wentworth P
    Chembiochem; 2009 May; 10(8):1340-3. PubMed ID: 19402090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of complement C3 and C4 in the human kidney.
    Welch TR; Beischel LS; Witte DP
    J Clin Invest; 1993 Sep; 92(3):1451-8. PubMed ID: 8376597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation.
    Chu CT; Pizzo SV
    Lab Invest; 1994 Dec; 71(6):792-812. PubMed ID: 7528831
    [No Abstract]   [Full Text] [Related]  

  • 30. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.
    Takayama Y; Takada F; Takahashi A; Kawakami M
    J Immunol; 1994 Mar; 152(5):2308-16. PubMed ID: 8133044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The covalent binding reaction of C3 and C4.
    Law SK
    Ann N Y Acad Sci; 1983; 421():246-58. PubMed ID: 6586101
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalysed hydrolysis--the complement quickstep.
    Law SK; Dodds AW
    Immunol Today; 1996 Mar; 17(3):105. PubMed ID: 8820264
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemical labelling of active serum thioester proteins for quantification.
    Holm L; Ackland GL; Edwards MR; Breckenridge RA; Sim RB; Offer J
    Immunobiology; 2012 Feb; 217(2):256-64. PubMed ID: 21852021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study.
    Büchler M; Malfertheiner P; Schoetensack C; Uhl W; Beger HG
    Int J Pancreatol; 1986 Oct; 1(3-4):227-35. PubMed ID: 2445867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat-induced fragmentation of human plasma fibronectin.
    Miekka SI
    Biochim Biophys Acta; 1983 Nov; 748(3):374-80. PubMed ID: 6196054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 38. Conformational states of a bacterial α2-macroglobulin resemble those of human complement C3.
    Neves D; Estrozi LF; Job V; Gabel F; Schoehn G; Dessen A
    PLoS One; 2012; 7(4):e35384. PubMed ID: 22530012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterial protein HbhA binds human complement component C3.
    Mueller-Ortiz SL; Wanger AR; Norris SJ
    Infect Immun; 2001 Dec; 69(12):7501-11. PubMed ID: 11705926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active sites in complement component C3 mapped by mutations at indels.
    Ogata RT; Ai R; Low PJ
    J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.